The Cleveland Clinic notes that RSV causes at least 60,000 to 160,000 hospitalizations per year among adults age 65 or older ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a lower group of adults aged 18 to 59 years at increased risk for disease.